BR9406924A - Composto processo para preparar o mesmo formulaçao farmaceutica e uso de um composto - Google Patents
Composto processo para preparar o mesmo formulaçao farmaceutica e uso de um compostoInfo
- Publication number
- BR9406924A BR9406924A BR9406924A BR9406924A BR9406924A BR 9406924 A BR9406924 A BR 9406924A BR 9406924 A BR9406924 A BR 9406924A BR 9406924 A BR9406924 A BR 9406924A BR 9406924 A BR9406924 A BR 9406924A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- preparing
- pharmaceutical formulation
- same pharmaceutical
- compound process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE19939302333A SE9302333D0 (sv) | 1993-07-06 | 1993-07-06 | New compounds |
| PCT/SE1994/000664 WO1995001967A1 (en) | 1993-07-06 | 1994-07-05 | Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9406924A true BR9406924A (pt) | 1996-07-30 |
Family
ID=20390540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9406924A BR9406924A (pt) | 1993-07-06 | 1994-07-05 | Composto processo para preparar o mesmo formulaçao farmaceutica e uso de um composto |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5747515A (pt) |
| EP (1) | EP0707573A1 (pt) |
| JP (1) | JPH08512313A (pt) |
| CN (1) | CN1044705C (pt) |
| AU (1) | AU691191B2 (pt) |
| BR (1) | BR9406924A (pt) |
| CA (1) | CA2164876A1 (pt) |
| CZ (1) | CZ4196A3 (pt) |
| FI (1) | FI960077A0 (pt) |
| HU (1) | HUT74673A (pt) |
| IS (1) | IS1742B (pt) |
| NO (1) | NO305862B1 (pt) |
| NZ (1) | NZ268690A (pt) |
| PL (1) | PL179021B1 (pt) |
| RU (1) | RU2137763C1 (pt) |
| SE (1) | SE9302333D0 (pt) |
| SK (1) | SK281025B6 (pt) |
| WO (1) | WO1995001967A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2774596B1 (fr) * | 1998-02-11 | 2000-03-17 | Rhone Poulenc Rorer Sa | Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer |
| EP1073640B1 (en) * | 1998-04-23 | 2005-04-13 | Takeda Pharmaceutical Company Limited | Naphthalene derivatives, their production and use |
| US6503935B1 (en) | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
| US6156775A (en) * | 1999-03-01 | 2000-12-05 | Novartis Ag | Use of fluorinated triazoles in treating affective and attention disorders |
| WO2000078727A1 (fr) | 1999-06-22 | 2000-12-28 | Takeda Chemical Industries, Ltd. | Methode de preparation de derives d'imidazole |
| SE9904177D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
| WO2008064317A1 (en) * | 2006-11-22 | 2008-05-29 | University Of Medicine And Dentistry Of New Jersey | Lipophilic opioid receptor active compounds |
| US9150527B2 (en) * | 2011-08-30 | 2015-10-06 | Innocrin Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| CN104932538B (zh) * | 2015-07-03 | 2018-02-23 | 中国计量科学研究院 | 光机旋转装置 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE121520C (pt) * | ||||
| GB2101114B (en) * | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
| US4649146A (en) * | 1983-01-31 | 1987-03-10 | Fujisawa Pharmaceutical Co., Ltd. | Thiazole derivatives and pharmaceutical composition comprising the same |
| FR2625199B1 (fr) * | 1987-12-23 | 1991-03-22 | Irceba | Derives oxyimino du thiazole, procede de preparation et utilisation en therapeutique |
| JPH01249760A (ja) * | 1988-03-29 | 1989-10-05 | Yamaha Corp | ホトクロミック化合物 |
| JPH0291076A (ja) * | 1988-09-28 | 1990-03-30 | Tokuyama Soda Co Ltd | フォトクロミック性化合物及びその製造方法 |
| TW224461B (pt) * | 1990-09-18 | 1994-06-01 | Ciba Geigy Ag | |
| US5177079A (en) * | 1991-01-31 | 1993-01-05 | Warner-Lambert Company | 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents |
| CA2099868C (en) * | 1991-01-31 | 2002-04-02 | Thomas Richard Belliotti | Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| GB9125924D0 (en) * | 1991-06-18 | 1992-02-05 | Orion Yhtymae Oy | Stereoisomers of an imidazole derivative |
-
1993
- 1993-07-06 SE SE19939302333A patent/SE9302333D0/xx unknown
-
1994
- 1994-06-23 IS IS4183A patent/IS1742B/is unknown
- 1994-07-05 PL PL94312427A patent/PL179021B1/pl unknown
- 1994-07-05 RU RU96102574A patent/RU2137763C1/ru active
- 1994-07-05 US US08/379,467 patent/US5747515A/en not_active Expired - Fee Related
- 1994-07-05 HU HU9503742A patent/HUT74673A/hu unknown
- 1994-07-05 SK SK1599-95A patent/SK281025B6/sk unknown
- 1994-07-05 NZ NZ268690A patent/NZ268690A/en unknown
- 1994-07-05 CN CN94192705A patent/CN1044705C/zh not_active Expired - Fee Related
- 1994-07-05 CZ CZ9641A patent/CZ4196A3/cs unknown
- 1994-07-05 EP EP94921148A patent/EP0707573A1/en not_active Withdrawn
- 1994-07-05 CA CA002164876A patent/CA2164876A1/en not_active Abandoned
- 1994-07-05 BR BR9406924A patent/BR9406924A/pt not_active Application Discontinuation
- 1994-07-05 WO PCT/SE1994/000664 patent/WO1995001967A1/en not_active Application Discontinuation
- 1994-07-05 JP JP7503999A patent/JPH08512313A/ja active Pending
- 1994-07-05 AU AU71978/94A patent/AU691191B2/en not_active Ceased
-
1996
- 1996-01-04 NO NO960029A patent/NO305862B1/no not_active IP Right Cessation
- 1996-01-08 FI FI960077A patent/FI960077A0/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI960077A (fi) | 1996-01-08 |
| SK159995A3 (en) | 1996-06-05 |
| HUT74673A (en) | 1997-01-28 |
| AU7197894A (en) | 1995-02-06 |
| AU691191B2 (en) | 1998-05-14 |
| HU9503742D0 (en) | 1996-02-28 |
| IS1742B (is) | 2000-02-21 |
| NO960029D0 (no) | 1996-01-04 |
| PL179021B1 (pl) | 2000-07-31 |
| RU2137763C1 (ru) | 1999-09-20 |
| SE9302333D0 (sv) | 1993-07-06 |
| PL312427A1 (en) | 1996-04-29 |
| WO1995001967A1 (en) | 1995-01-19 |
| FI960077A0 (fi) | 1996-01-08 |
| CZ4196A3 (en) | 1996-06-12 |
| SK281025B6 (sk) | 2000-11-07 |
| IS4183A (is) | 1995-01-07 |
| NZ268690A (en) | 1997-11-24 |
| NO305862B1 (no) | 1999-08-09 |
| NO960029L (no) | 1996-01-04 |
| CN1044705C (zh) | 1999-08-18 |
| EP0707573A1 (en) | 1996-04-24 |
| CA2164876A1 (en) | 1995-01-19 |
| US5747515A (en) | 1998-05-05 |
| CN1126990A (zh) | 1996-07-17 |
| JPH08512313A (ja) | 1996-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9501770A (pt) | Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto | |
| BR9602705A (pt) | Composto composição farmacéutica processo para a preparação de um composto e uso | |
| BR1100323A (pt) | Composto, uso de um composto, composição farmacêutica e processo para preparar um composto | |
| BR9600821A (pt) | Composto formulação farmacêutica e processo para a preparação de um composto | |
| BR9404809A (pt) | Composto, uso, formulação farmacêutica e processo para preparar um composto | |
| BR1100850A (pt) | Composto, processo para a preparação de um composto, e, composição farmacêutica | |
| BR9505107A (pt) | Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso | |
| BR9610988A (pt) | Composto uso do mesmo fomulação farmacêutica e processo para produção do composto | |
| BR9611986A (pt) | Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos | |
| BR9609780A (pt) | Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto | |
| BR9204361A (pt) | Composto e processo para sua preparacao formulacao farmaceutica e intermediario | |
| BR9504509A (pt) | Composto processo para sua preparaçao e formulaçao farmaceûtica | |
| BR9301137A (pt) | Composto,formulacao farmaceutica,sulfonamida e processo para sua preparacao | |
| BR9602150A (pt) | Compostos processo para sua preparação processo para a produção de uma formulação farmacêutica formulação farmacêutica e uso | |
| BR9103036A (pt) | Composto,formulacao farmaceutica e processo para a preparacao do composto | |
| BR9600339A (pt) | Compostos composições farmacêuticas processo para a preparação de um composto e uso dos mesmos | |
| BR9607264A (pt) | Composto derivado do isotiuréia composição farmacêutica uso de tal composto e processo para a preparação dos mesmos | |
| BR9602025A (pt) | Composto composição farmacêutica uso e processo para a preparação de um composto | |
| BR9302389A (pt) | Composto,formulacao farmaceutica e processo para preparar o composto | |
| BR9100907A (pt) | Aplicacao de compostos e processo para a preparacao de poliuretanas | |
| BR9301273A (pt) | Composto,formulacao farmaceutica,processo para preparar um composto e composto obtido | |
| BR9406924A (pt) | Composto processo para preparar o mesmo formulaçao farmaceutica e uso de um composto | |
| BR9601178A (pt) | Composição uso processo para a estabilização de um polímero processo para a preparação de um composto e composto obtido | |
| BR9606596A (pt) | Composto processo para preparar um composto composição cosmética ou farmacéutica e uso de um composto | |
| BR9800718A (pt) | Composto esteróide composição farmacéutica uso de um composto esteróide e processo para a preparação de um estróide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |